Insulin resistance, typically defined by impairment of insulin-mediated actions on glucose uptake, affects a wide range of tissues including adipose, skeletal muscle, and the vascular endothelium. Insulin, via a sequence of intracellular signals, activates endothelial nitric oxide synthase (eNOS) (1) and increases production of nitric oxide. Reductions in the bioavailability of nitric oxide (NO) are associated with atherogenesis. Impaired insulin action, when assessed by fasting serum insulin level or the homeostasis model assessment (HOMA-IR) (2, 3) , is associated with atherosclerosis and an increased risk of myocardial infarction. Insulin resistance is associated with endothelial dysfunction (4) and may serve as a link between insulin resistance and atherosclerosis.
Forty seven non-smoking women, including 12 with type 2 diabetes, 10 with polycystic ovary syndrome (PCOS), 6 with non-humanimmunodeficiency virus (HIV)-negative lipodystrophic diabetes, and 19 healthy controls were recruited through newspaper advertisement and from the Joslin Diabetes Center. All subjects underwent screening medical history, physical examination, and laboratory analysis including complete blood count, serum electrolytes, glucose, blood urea nitrogen, and creatinine, total cholesterol, and low density lipoprotein (LDL) cholesterol. Among the type 2 diabetic, PCOS, and healthy control subjects, those with hypertension, history of tobacco use, LDL or total cholesterol greater than the 75 Insulin resistance, however, is not a single entity and occurs as a consequence of a variety of mechanisms and disparate clinic presentations, unified phenotypically by impaired insulin-mediated glucose uptake. Because the mechanisms of insulin resistance vary in different conditions, its impact on other tissues remains unclear. Determining the effect of various insulin resistant states on endothelial function may provide insight in NO bioavailability in each disease and contribute to our understanding of a greater prevalence of atherosclerosis in insulin resistant patients.
Accordingly, we sought to investigate the role of insulin resistance on endothelial function in three distinct populations of insulin resistant women (polycystic ovary syndrome (PCOS), type 2 diabetes and lipodystrophic diabetes) compared with healthy subjects. We also measured a marker of inflammation (C-reactive protein (CRP)) and two adipokines (adiponectin and free fatty acids) to determine whether these factors, known to be abnormal in insulin resistance, may serve as mechanism of vascular dysfunction across insulin resistance states.
Research Design and Methods Subjects th percentile for age and gender, cardiovascular disease, use of a thiazolidinedione, or other significant disease were excluded. Women with PCOS had 6 or fewer menses per year in addition to hyperandrogenemia defined by either total testosterone > 58 ng/dl (2 nmol/L) and/or non-sex hormone binding globulin bound testosterone (unbound testosterone or uT) >15 ng/dl (0.5 nmol/L) levels greater than two standard deviations above the mean value that established in reproductively normal women aged 18-40 years old in the early follicular phase of the menstrual cycle. Other causes of anovulation and hyperandrogenemia were excluded by appropriate laboratory tests. Patients with lipodystrophic diabetes, because of their rarity, were enrolled despite extant atherosclerosis or risk factors (except for smoking) for atherosclerosis.
The lipodystrophic subjects included two with familial partial lipodystrophy (FPLD), two with Dunnigan's FPLD, one with familial partial lipodystrophy -mandibuloacral dysplasia variety, and one with acquired lipodystrophy after dermatomyosits. One subject was blind, had renal insufficiency, and peripheral arterial disease and died 3 months after the study; one subject had renal insufficiency and died 1 year after the study; and one subject had coronary artery disease. Two lipodystrophic subjects were taking ACE inhibitors, and they withheld these medications for 24 hours prior to vascular testing. Diabetes medications were held on the day of study. Other potential subjects taking an angiotensin converting enzyme (ACE) inhibitor, angiotensin receptor blocker, or statin were excluded. All participants provided written, informed consent. The protocol was approved by the Human Research Committees of the Joslin Diabetes Center and the Brigham and Women's Hospital.
All subjects were studied in the morning in the post-absorptive state, fasting after the previous midnight. Cyclooxygenase inhibitors, alcohol, and caffeine were prohibited for 24 hours prior to the study. Subjects were studied in a quiet, temperaturecontrolled, dimly-lit room, after resting supine for a minimum of 5 minutes. High-resolution B-mode ultrasonography of the brachial artery was performed using a Toshiba 270 SSA (Toshiba America Medical Systems, Inc., Tustin, CA) ultrasound machine and 7.5 MHz linear array probe. The brachial artery was imaged longitudinally just proximal to the antecubital fossa. Transducer position was adjusted to obtain optimal images of the near and far wall of the intima. Images were simultaneously recorded on super VHS video tape.
The video output and electrocardiographic signal of the ultrasound machine were connected to a computer equipped with a Data Translation framegrabber videocard, (Dataviz, Trumbull, CT). The 'R' wave on the electrocardiogram served as a trigger to acquire frames at enddiastole. After baseline image acquisition, a forearm sphygmomanometric cuff was inflated to suprasystolic pressure (200 mm Hg) for five minutes. Upon cuff release, reactive hyperemia causes flow to increase through the brachial artery subserving the forearm.
Flow-induced, endotheliumdependent vasodilation of the brachial artery was determined by acquiring images at one minute after cuff deflation. Flow-mediated vasodilation at this time point is largely endothelium-dependent and nitric oxide mediated, and can be inhibited by administration of the nitric oxide synthase antagonist, N Vascular Reactivity Studies Total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol and blood glucose levels were measured by standard laboratory techniques. hs-CRP levels were measured using the Beckman LX-20 (Beckman Coulter, Brea, CA). This assay has been validated against the Dade Behring hsCRP method and has an inter and intraassay CV of < 8%. Adiponectin levels were measured using a sandwich ELISA (Linco Research, St. Charles, MO) and had an interand intra-assay CV of <9%. Insulin levels were measured using a two-site immunoassay (Linco Research, St. Charles, MO) with an inter and intra-assay CV of <11%. Free fatty acids in serum were measured using reagents from Wako diagnostics. Free fatty acids were G -monomethyl-L-arginine (5). Ten minutes after cuff release, the brachial artery was imaged again to re-establish basal conditions. Then, to determine endotheliumindependent vasodilation, subjects received 0.4 mg of nitroglycerin, sublingually. The brachial artery was imaged three minutes later. Brachial artery blood flow velocity was determined via time-velocity integral measurement.
Nitroglycerin was not administered if the systolic blood pressure was below 110 mm Hg or the subject refused nitroglycerin, usually to avoid a severe headache during the second and third visits.
Laboratory Analyses measured based the acylation of coenzyme A(CoA) by the fatty acids in the presence of added acyl-CoA synthetase (Wako Chemicals, Richmond, VA). The acyl-CoA produced is oxidized by added acyl-CoA oxidase (ACOD) generating hydrogen peroxide that is measured spectrophotometrically. The inter-and intraassay CVs for this assay are between 3-7%. The homeostasis model assessment (HOMA-IR) of insulin resistance was calculated as fasting glucose x fasting insulin/22.5 (6).
Baseline characteristics are presented in Table 1 . Type 2 diabetic subjects were older than lipodystrophic diabetic, PCOS, and healthy control subjects. Hemoglobin A1c was 7.8±1.9% in the subjects with type 2 diabetes and 8.8±2.3% in the subjects with lipodystrophy. Of the12 subjects with type 2 diabetes, glucose lowering was achieved in 7 with a sulfonylurea alone, in 2 with insulin alone, and in 3 with metformin and a sulfonylurea.
All lipodystrophic subjects were taking high dose insulin and 2 were taking metformin. Total cholesterol and low density lipoprotein (LDL) cholesterol levels, blood pressure, and body mass index did not differ significantly among the groups. High density lipoprotein (HDL) cholesterol levels were lower and triglycerides levels were higher in each insulin resistant group compared with healthy subjects. Insulin resistance, as measured by HOMA-IR, was greater in lipodystrophy (27.6 ± 16.4), PCOS (6.6 ± 1.9), and type 2 diabetic subjects (6.1 ± 1.4) compared to control subjects (2.3 ± 0.4) (p = 0.001, by ANOVA). Similarly, insulin levels and glucose levels were higher in the insulin resistant groups compared to healthy control subjects.
The insulin level and HOMA-IR in lipodystrophic subjects were more than twice that of any other group.
Statistical Methods Descriptive measures are reported as means ± standard deviation (SD). Experimental measures are reported as means ± standard error (SE). Demographic data, arterial diameter, reactive hyperemia, and flow-mediated and nitroglycerin-mediated vasodilation were compared using analysis of variance (ANOVA). Post-hoc comparisons were made using Dunnett testing with the healthy control group as the referent. Correlation with Spearman's rho analysis was performed to assess the effects of baseline characteristics and measured parameters on vascular function and insulin resistance. Statistical significance was accepted at the 95% confidence level (p < 0.05). All statistics were run on SPSS Base 11.0.04 (SPSS, Inc., Chicago, IL).
Flow-mediated vasodilation was reduced in type 2 diabetic subjects (3.4 ± 1.3%) compared with healthy control subjects (7.3 ± 1.1%), but was unexpectedly preserved in subjects with lipodystrophy (7.7 ± 1.2%) and with PCOS (9.9 ± 0.7%) (p = 0.005 by ANOVA, Figure 1 ). In post-hoc testing, flow-mediated vasodilation was significantly reduced in subjects with type 2 diabetes mellitus when compared to healthy subjects (p = 0.02). This was not accounted for by differences in baseline arterial diameter. Baseline arterial diameter was similar in each group: 3.11 ± 0.12 mm in healthy control subjects, 3.27 ± 0.14 mm in type 2 diabetic subjects, 3.20 ± 0.15 mm in PCOS, and 3.31 ± 0.29 mm in lipodystrophic subjects, (p > 0.2).
Results
Nitroglycerin-mediated vasodilation was reduced in both type 2 diabetic (15.2 ± 2.0%) and lipodystrophic subjects (16.7 ± 3.6%) compared with healthy control subjects (24.6 ± 2.4%) and PCOS subjects (20.7 ± 2.8%) (p = 0.02, by ANOVA, Figure 2 ). In post-hoc testing, nitroglycerin-mediated vasodilation was reduced in subjects with type 2 diabetes mellitus (p = 0.02) significantly and trended towards attenuation in lipodystrophic subjects (p = 0.09) when compared to healthy subjects. Six subjects did not receive nitroglycerin. One PCOS and 3 healthy control subjects had systolic blood pressure below our cutoff level of 110 mm/Hg, while 2 subjects with type 2 diabetes refused.
Free fatty acids (FFA) were significantly higher in each insulin resistant group compared with healthy subjects (p = 0.004, by ANOVA) ( Table 1) . Adiponectin levels were significantly lower in the type 2 diabetic and PCOS groups compared with healthy control (p = 0.04, by ANOVA) and lipodystrophic subjects. CRP was not significantly different among the four groups (p > 0.2, by ANOVA).
Insulin resistance, whether measured by HOMA-IR or fasting insulin level, correlated inversely with HDL and adiponectin levels and directly with triglycerides levels and BMI (Table 2) . Free fatty acid levels correlated indirectly with HDL (r = -0.31, p = 0.04) and directly with triglycerides levels (r = 0.39, p =0.008). Neither markers of insulin sensitivity, BMI, CRP, nor adipokines correlated with endothelium-dependent vasodilation or with endothelium-independent vasodilation. Glucose levels correlated inversely with endothelium-independent vasodilation (r = -0.46, p = .009) but not endotheliumdependent vasodilation.
In type 2 diabetes mellitus, serine phosphorylation of the insulin receptor substrate attenuates normal activation of phosphatidylinositol 3-kinase and AKT attenuating endothelial nitric oxide synthase activity (10) . The molecular basis for defects in insulin signaling differs in lipodystrophy and PCOS compared with type 2 diabetes. For example, lamin or peroxisome proliferator-activated
Conclusions
In this investigation, we evaluated vascular function in subjects with different types of insulin resistance including those with type 2 diabetes mellitus, lipodystrophic diabetes, and polycystic ovary syndrome, and compared those patients with healthy control subjects. Insulin-resistance, as determined by HOMA-IR, was more profound in each insulin resistant group compared with control subjects. Despite the presence of insulin resistance, endothelium-dependent vasodilation was reduced only in subjects with type 2 diabetes. Endothelial function was preserved in subjects with lipodystrophic diabetes and with PCOS. Our results do not support a direct relationship between insulin resistance and endothelial function across a spectrum of insulin resistant states. This was surprising, for worsening insulin resistance is broadly associated with increases in atherosclerosis across these same disease states, from least in PCOS to most in lipodystrophic diabetes (7) (8) (9) . Phenotypic variations in insulin-affected tissues suggest that the mechanism of insulin resistance, instead of the severity of either insulin resistance or glucose disturbance, may be relevant to understanding the specific effect of these disease states on vascular function.
receptor-gamma mutations in some forms of lipodystrophy but not common type 2 diabetes or PCOS suggest a different origin for the resistance to insulin action (11) . Differing responses to leptin administration (12), PPAR-γ therapy (13) , and variations in insulin-mediated FFA and ketone body suppression (14, 15) further indicate that lipodystrophy causes insulin resistance differently than type 2 diabetes.
Previous investigations by Dunaif and colleagues have demonstrated increased insulin receptor serine phosphorylation and decreased IRS-1 tyrosine phosphorylation (16, 17) in obese women with PCOS. Several studies, including ours, demonstrate preserved endothelial function in women with PCOS who are either non-obese or without morbid obesity (18, 19) , but this remains controversial (20) (21) (22) .
The presence of obesity may contribute importantly to the attenuation in vascular function in this condition. While overweight, our cohort of PCOS was less obese than those with attenuated vascular function (22) , and endothelial function was similarly preserved in lean women with PCOS (18, 19) . Supporting the concept of an effect of obesity on vascular function, Baron and colleagues found that insulin-mediated increases in leg blood flow and skeletal muscle glucose uptake were reduced in obese subjects and those with type 2 diabetes mellitus (4, 23 (25, 26) . Endotheliumdependent vasodilation correlates with glycemia in healthy subjects, subjects with impaired fasting glucose, and subjects with type 2 diabetes (27, 28) . Improvements in glycemia in subjects with type 2 diabetes improve endothelial function (29) . Despite this evidence, in our cohort, the lipodystrophic subjects had the highest fasting glucose and yet had normal endotheliumdependent vasodilation. An expected trend was noted in the correlation between glucose levels and endothelium-dependent vasodilation when only diabetic and healthy controls were examined (data not shown), but this only supports the lack of a relationship across insulin resistant states.
Adiponectin expression in our cohort was lower in type 2 diabetic and PCOS subjects when compared to healthy subjects. However, adiponectin levels were not decreased in the lipodystrophic subjects. Adiponectin levels in the lipodystrophic subjects were similar to the data of Haque and colleagues (30) in patients with familial partial lipodystrophy, which were relatively preserved in comparison to patients with congenital generalized lipoatrophy, which were not represented in our cohort. Additionally, while we did find the expected strong association between adiponectin and HDL, we did not find an association between either adiponectin or free fatty acid levels and endothelium-dependent vasodilation across the range of healthy and insulin resistant subjects. This is consistent with our observations regarding adiponectin in offspring of patients with type 2 diabetes mellitus (31). Other investigators have reported associations between adiponectin and vascular function, but a review of the literature reveals an inconsistent link between adipocyte products and vascular function. Adioponectin has been correlated to reactive hyperemia in healthy Japanese subjects (32) , to nitroglycerin-mediated, endotheliumindependent vasodilation but not endothelium-dependent vasodilation in healthy Spanish subjects (33), and weakly with endothelium-dependent vasodilation (r < 0.3) in a large sample of type 2 diabetic and healthy controls subjects in Hong Kong (34).
Adipokines
Likewise, there was no correlation between FFA and endothelium-dependent vaosodilation in our subjects. However, as expected free fatty acid levels were increased in each insulin resistance state compared with healthy controls; yet, the extent of insulin resistance did not correlate with FFA levels. Also, triglycerides were directly associated and in HDL was inversely associated with insulin resistance. Similarly, across a population of healthy control, type 2 diabetic subjects without microalbumineria, and type 2 subjects with albumineria, free fatty acid levels did not associate with endotheliumdependent vasodilation (35) .
Moreover, Ballotshafer and colleagues demonstrated no association between ambient free fatty acid levels and flow-mediated vasodilation in first degree relatives of patients with type 2 diabetes (36). Thus, abnormalities in these adipocyte factors in insulin resistance do not independently mediate vascular dysfunction across a range of insulin resistance states.
Inflammation Inflammation has been demonstrated to associate with endothelial dysfunction in healthy subjects and patients with coronary artery disease (37, 38) . Moreover, when inflammation is induced by vaccination, endothelial function is depressed and blocking the increase in inflammatory cytokines prevents endothelial dysfunction (39, 40) . Despite this relationship between inflammation and endothelial function in nondiabetic populations, several studies have demonstrated that CRP does not correlate with vascular function in diabetic subjects (41) (42) (43) . Similarly, in our cohort, CRP levels did not vary significantly across our insulin resistant populations and did not correlate with endothelial function. CRP, as one marker of inflammation, however, may not represent all inflammatory markers.
Vascular smooth muscle dysfunction The response to nitroglycerin was attenuated in subjects with type 2 and lipodystrophic diabetes mellitus. We have previously reported an impaired response to nitroglycerin in subjects with type 2 diabetes mellitus (44) , but this is the first report of a similar finding in subjects with lipodystrophic diabetes.
Markers of insulin resistance, adipokines, and inflammation did not associate with vascular smooth muscle function. Glucose levels correlated inversely with smooth muscle function. The attenuation in endothelium-independent vasodilation may relate to chronic hyperglycemia as reflected in attenuation of nitroglycerin-mediated vasodilation in diabetes (44, 45) . Despite the attenuation in endothelium-independent vasodilation in the subjects with lipodystrophic diabetes, flowmediated, endothelium-dependent vasodilation was preserved. These results suggest that endothelial vasodilator production was sufficient to maintain endothelium-dependent vasodilation despite attenuations in vascular smooth muscle function.
Limitations In this investigation of vascular function in insulin resistance, HOMA-IR was used to approximate insulin resistance. This measure, in large part, reflects the relationship between insulin production and hepatic glucose output and is reported to correlate well with dynamic measures of insulin resistance, such as a euglycemic clamp or the minimal model (46) . However, HOMA-IR may underestimate the severity of insulin resistance in subjects with long-standing type 2 diabetes because of an inability to make insulin. It is unlikely that insulin resistance the type 2 diabetic subjects would approach the same severity in subjects with lipodystrophy. Lipodystrophic subjects were the most insulin resistant and had preserved endothelial function unlinking a direct relationship between the two parameters.
In studying these populations, the number of subjects with lipodystrophy was small compared to the other groups because of their rarity in the population. Moreover, two of the subjects were taking ACE inhibitors which may improve endothelial function while 3 had microvascular disease or atherosclerosis which should worsen it.
Although these study conditions were imperfect, the similarity of vascular function within subjects with lipodystrophy and between them and healthy control subjects suggests our observations are valid and not likely to be altered if a greater number of lipodystrophic patients were included.
Age varied significantly among the groups. Several investigations have noted that older subjects have attenuated endothelial function compared with younger controls (47) (48) (49) (50) . Despite this difference, in this study, endothelial function remained significantly different among the groups after controlling for age.
Conclusion How, then, to explain our findings? Our measure of insulin resistance is strongly correlated with impairment of insulinmediated skeletal-muscle glucose uptake. Although there is a link between the skeletal muscle defect and vascular defect in obesity/diabetes, different vascular insulin signaling disturbances are likely operational in the other insulin resistance states. Insulin levels in the lipodystrophic diabetic subjects were markedly higher than every other group, possibly stimulating eNOS enough to overcome the disturbances in vascular smooth muscle function demonstrated in our cohort.
Thus, the effects of insulin resistance on vascular function vary according to origin of impaired insulin signaling. Lipodystrophic and PCOS patients have normal endothelial function, indicative of preserved endothelial insulin signaling, despite impaired glucose handling. Abnormal endothelium-dependent vasodilation in subjects with type 2 diabetes mellitus suggests that attenuated endothelial activation of PI-3 kinase and Akt importantly affects endothelial function in this insulin resistance disorder. Mechanisms of insulin resistance that are associated with an increased risk of atherosclerosis require better characterization to explain the variations in bioavailability of nitric oxide and risk of atherosclerosis. (A) The mean percent increase in brachial artery size 1 minute after cuff release compared with baseline is illustrated. (B) The mean percent increase in brachial artery size 3 minutes after sublingual nitroglycerin administration compared with baseline is illustrated.
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